20 February 2020
Visiongain has launched a new pharma report Bronchoscopes Market Report 2020-2030: Prospects by Use (Reusable, Disposable), Type (Rigid, Flexible, Accessories (Video, Fiberoptic, Hybrid)), Application (Bronchial Diagnosis, Bronchial Treatment), End User (Hospitals, Clinics & Ambulatory Surgical Centers (ASC), Others), and Geography.
The global bronchoscopes market is projected to grow at a lucrative CAGR of ~8% and anticipated to surpass USD 38 billion by 2030.
Bronchoscopes are medical devices that are mounted from the airway of the mouth or nose and sometimes tracheostomically to observe distal branches of the bronchi. Bronchoscopes are most commonly used in the diagnosis of tumors, infection, inflammation, foreign bodies, and lung bleeding, and are also used in airway surgery.
Growing prevalence of respiratory tract diseases such as lung cancer and COPD, growing preference for minimally invasive procedures and increasing number of bronchoscopy procedures are some of the key factors that are expected to drive market growth over the forecast period. Additional factors driving the market growth are increasing geriatric population and rising healthcare spending. The high cost of devices and the risk of infection, however, may restrict the market growth.
Also, over 45,000 new cases of lung cancer are diagnosed each year, according to Cancer Research UK. However, according to the World Cancer Research Fund International, in developing countries about lung cancer accounted for 58% of cases, which can be due to the alarming prevalence of a host of respiratory diseases. Therefore, the demand for bronchoscopes is anticipated to boost over the forecast period.
The disposable devices are anticipated to witness the highest CAGR over the forecast period owing to its affordability, especially those that have recently been launched on the market. Also, factors such as no cross-contamination, instant availability, and no cost of reprocessing are fueling market growth.
The global bronchoscopes market is dominated by the North American region followed by the European region. The dominance of the North American bronchoscopes market is attributed to rising cases of lung cancer and the presence of major & established players. The United States is the largest market globally due to the wide adoption of these devices coupled with the federal government's favorable reimbursement policies.
Due to significant growth opportunities in Japan, China, and India, the Asia Pacific market is expected to witness remarkable growth over the forecast period. The market is driven by factors such as growing patient pool, high unmet clinical needs, growing health insurance, rising technological advances, increased healthcare expenditure, and an increasing number of global companies seeking to meet high unmet medical needs in these countries.
Some of the major players operating in this industry are Ambu A/S, Boston Scientific Corporation, Cochlear LIMITED, Cogentix Medical, Cook Medical, EFER Endoscopy, Entellus Medical,INC, Fujifilm Holdings Corporation, GN Store NORD A/S, Hoya Corporation (Pentax Medical), Johnson & Johnson, Karl Storz GmbH, Lymol Medical, MED-EL, Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Scholly Fiberoptic GMBH, Teleflex Incorporated, among other prominent players.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.